{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:14:57Z","timestamp":1785500097943,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009699","name":"Fondazione Generali","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007382","name":"Fondation Motrice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004909","name":"Universidade Federal do Rio Grande do Sul, Brazil","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004909","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and purpose<\/jats:title>\n                <jats:p>The only validated treatment to prevent brain damage associated with hypoxia\u2013ischemia (HI) encephalopathy of the newborn is controlled hypothermia with limited benefits. Additional putative neuroprotective drug candidates include sildenafil citrate, a phosphodiesterase-type 5 inhibitor. The main objective of this preclinical study is to assess its ability to reduce HI-induced neuroinflammation, in particular through its potential effect on microglial activation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>HI was induced in P10 Sprague\u2013Dawley rats by unilateral carotid permanent artery occlusion and hypoxia (HI) and treated by either hypothermia (HT) alone, Sildenafil (Sild) alone or combined treatment (SildHT). Lesion size and glial activation were analyzed by immunohistochemistry, qRT-PCR, and proteomic analyses performed at P13.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>None of the treatments was associated with a significant early reduction in lesion size 72h after HI, despite significant changes in tissue loss distribution. Significant reductions in both Iba1\u2009+\u2009(within the ipsilateral hemisphere) and GFAP\u2009+\u2009cells (within the ipsilateral hippocampus) were observed in SildHT group, but not in the other treatment groups. In microglia-sorted cells, pro-inflammatory markers, i.e. Il1b, Il6, Nos2, and CD86 were significantly downregulated in SildHT treatment group only. These changes were restricted to the ipsilateral hemisphere, were not evidenced in sorted astrocytes, and were not sex dependent. Proteomic analyses in sorted microglia refined the pro-inflammatory effect of HI and confirmed a biologically relevant impact of SildHT on specific molecular pathways including genes related to neutrophilic functions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that Sildenafil combined with controlled hypothermia produces maximum effect in mitigating microglial activation induced by HI through complex proteomic regulation. The reduction of neuroinflammation induced by Sildenafil may represent an interesting therapeutic strategy for neonatal neuroprotection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-024-03022-w","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:02:07Z","timestamp":1706000527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synergistic effect of sildenafil combined with controlled hypothermia to alleviate microglial activation after neonatal hypoxia\u2013ischemia in rats"],"prefix":"10.1186","volume":"21","author":[{"given":"Pansiot","family":"Julien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Zinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Bonnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"El Kamouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Odorcyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie-Fleur","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Broussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"3022_CR1","doi-asserted-by":"publisher","first-page":"101265","DOI":"10.1016\/j.siny.2021.101265","volume":"26","author":"S McIntyre","year":"2021","unstructured":"McIntyre S, Nelson KB, Mulkey SB, Lechpammer M, Molloy E, Badawi N. Neonatal encephalopathy: focus on epidemiology and underexplored aspects of etiology. Semin Fetal Neonatal Med. 2021;26:101265. https:\/\/doi.org\/10.1016\/j.siny.2021.101265.","journal-title":"Semin Fetal Neonatal Med."},{"key":"3022_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.clp.2012.09.008","volume":"39","author":"S Shankaran","year":"2012","unstructured":"Shankaran S. Hypoxic-ischemic encephalopathy and novel strategies for neuroprotection. Clin Perinatol. 2012;39:919\u201329. https:\/\/doi.org\/10.1016\/j.clp.2012.09.008.","journal-title":"Clin Perinatol"},{"key":"3022_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c363","volume":"340","author":"AD Edwards","year":"2010","unstructured":"Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw A, Azzopardi D. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ. 2010;340: c363. https:\/\/doi.org\/10.1136\/bmj.c363.","journal-title":"BMJ"},{"key":"3022_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003311.pub3","volume":"2013","author":"SE Jacobs","year":"2013","unstructured":"Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013;2013: CD003311. https:\/\/doi.org\/10.1002\/14651858.CD003311.pub3.","journal-title":"Cochrane Database Syst Rev."},{"key":"3022_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic\u2013ischaemic encephalopathy. Early Hum Dev. 2010;86:329\u201338. https:\/\/doi.org\/10.1016\/j.earlhumdev.2010.05.010.","journal-title":"Early Hum Dev"},{"key":"3022_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2017.7218","volume":"318","author":"S Shankaran","year":"2017","unstructured":"Shankaran S, Laptook AR, Pappas A, McDonald SA, Das A, Tyson JE, Poindexter BB, Schibler K, Bell EF, Heyne RJ, et al. Effect of depth and duration of cooling on death or disability at age 18 months among neonates with hypoxic-ischemic encephalopathy: a randomized clinical trial. JAMA. 2017;318:57\u201367. https:\/\/doi.org\/10.1001\/jama.2017.7218.","journal-title":"JAMA"},{"key":"3022_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar M, Weiss MD. Hypoxic\u2013ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169:397\u2013403. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3269.","journal-title":"JAMA Pediatr"},{"key":"3022_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12974-022-02499-7","volume":"19","author":"KQ Zhou","year":"2022","unstructured":"Zhou KQ, Bennet L, Wassink G, McDouall A, Curtis MA, Highet B, Stevenson TJ, Gunn AJ, Davidson JO. Persistent cortical and white matter inflammation after therapeutic hypothermia for ischemia in near-term fetal sheep. J Neuroinflammation. 2022;19:139. https:\/\/doi.org\/10.1186\/s12974-022-02499-7.","journal-title":"J Neuroinflammation"},{"key":"3022_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnen\/nlx046","volume":"76","author":"M Ziemka-Nalecz","year":"2017","unstructured":"Ziemka-Nalecz M, Jaworska J, Zalewska T. Insights into the neuroinflammatory responses after neonatal hypoxia\u2013ischemia. J Neuropathol Exp Neurol. 2017;76:644\u201354. https:\/\/doi.org\/10.1093\/jnen\/nlx046.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3022_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1203\/01.PDR.0000144819.45689.BB","volume":"56","author":"AI Bartha","year":"2004","unstructured":"Bartha AI, Foster-Barber A, Miller SP, Vigneron DB, Glidden DV, Barkovich AJ, Ferriero DM. Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res. 2004;56:960\u20136. https:\/\/doi.org\/10.1203\/01.PDR.0000144819.45689.BB.","journal-title":"Pediatr Res"},{"key":"3022_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fneur.2015.00081","volume":"6","author":"S Fumagalli","year":"2015","unstructured":"Fumagalli S, Perego C, Pischiutta F, Zanier ER, De Simoni MG. The ischemic environment drives microglia and macrophage function. Front Neurol. 2015;6:81. https:\/\/doi.org\/10.3389\/fneur.2015.00081.","journal-title":"Front Neurol"},{"key":"3022_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1471-4159.2006.04162.x","volume":"100","author":"SP Denker","year":"2007","unstructured":"Denker SP, Ji S, Dingman A, Lee SY, Derugin N, Wendland MF, Vexler ZS. Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem. 2007;100:893\u2013904. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04162.x.","journal-title":"J Neurochem"},{"key":"3022_CR13","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/glia.23484","volume":"66","author":"M Fumagalli","year":"2018","unstructured":"Fumagalli M, Lombardi M, Gressens P, Verderio C. How to reprogram microglia toward beneficial functions. Glia. 2018;66:2531\u201349. https:\/\/doi.org\/10.1002\/glia.23484.","journal-title":"Glia"},{"key":"3022_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000328989","volume":"33","author":"M Czeh","year":"2011","unstructured":"Czeh M, Gressens P, Kaindl AM. The yin and yang of microglia. Dev Neurosci. 2011;33:199\u2013209. https:\/\/doi.org\/10.1159\/000328989.","journal-title":"Dev Neurosci"},{"key":"3022_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/jnr.24761","volume":"99","author":"R Shao","year":"2021","unstructured":"Shao R, Sun D, Hu Y, Cui D. White matter injury in the neonatal hypoxic\u2013ischemic brain and potential therapies targeting microglia. J Neurosci Res. 2021;99:991\u20131008. https:\/\/doi.org\/10.1002\/jnr.24761.","journal-title":"J Neurosci Res"},{"key":"3022_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-02295-2","author":"EJ Molloy","year":"2022","unstructured":"Molloy EJ, El-Dib M, Juul SE, Benders M, Gonzalez F, Bearer C, Wu YW, Robertson NJ, Hurley T, Branagan A, et al. Neuroprotective therapies in the NICU in term infants: present and future. Pediatr Res. 2022. https:\/\/doi.org\/10.1038\/s41390-022-02295-2.","journal-title":"Pediatr Res"},{"issue":"2598\u20132607","key":"3022_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.07.019","volume":"37","author":"KM Perez","year":"2015","unstructured":"Perez KM, Laughon M. Sildenafil in term and premature infants: a systematic review. Clin Ther. 2015;37(2598\u20132607): e2591. https:\/\/doi.org\/10.1016\/j.clinthera.2015.07.019.","journal-title":"Clin Ther"},{"key":"3022_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cellsig.2017.06.015","volume":"38","author":"JNE Olmestig","year":"2017","unstructured":"Olmestig JNE, Marlet IR, Hainsworth AH, Kruuse C. Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: a systematic review of preclinical studies. Cell Signal. 2017;38:39\u201348. https:\/\/doi.org\/10.1016\/j.cellsig.2017.06.015.","journal-title":"Cell Signal"},{"key":"3022_CR19","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1161\/01.str.0000034399.95249.59","volume":"33","author":"R Zhang","year":"2002","unstructured":"Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, Zhang L, Chopp M. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke. 2002;33:2675\u201380. https:\/\/doi.org\/10.1161\/01.str.0000034399.95249.59.","journal-title":"Stroke"},{"key":"3022_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1161\/STROKEAHA.113.003606","volume":"45","author":"C Charriaut-Marlangue","year":"2014","unstructured":"Charriaut-Marlangue C, Nguyen T, Bonnin P, Duy AP, Leger PL, Csaba Z, Pansiot J, Bourgeois T, Renolleau S, Baud O. Sildenafil mediates blood-flow redistribution and neuroprotection after neonatal hypoxia\u2013ischemia. Stroke. 2014;45:850\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.113.003606.","journal-title":"Stroke"},{"key":"3022_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12974-016-0560-4","volume":"13","author":"R Moretti","year":"2016","unstructured":"Moretti R, Leger PL, Besson VC, Csaba Z, Pansiot J, Di Criscio L, Gentili A, Titomanlio L, Bonnin P, Baud O, Charriaut-Marlangue C. Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain. J Neuroinflammation. 2016;13:95. https:\/\/doi.org\/10.1186\/s12974-016-0560-4.","journal-title":"J Neuroinflammation"},{"key":"3022_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainres.2006.10.098","volume":"1132","author":"L Li","year":"2007","unstructured":"Li L, Jiang Q, Zhang L, Ding G, Gang Zhang Z, Li Q, Ewing JR, Lu M, Panda S, Ledbetter KA, et al. Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res. 2007;1132:185\u201392. https:\/\/doi.org\/10.1016\/j.brainres.2006.10.098.","journal-title":"Brain Res"},{"key":"3022_CR23","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.3390\/cells10102766","volume":"10","author":"M Zinni","year":"2021","unstructured":"Zinni M, Pansiot J, Leger PL, El Kamouh M, Baud O. Sildenafil-mediated neuroprotection from adult to neonatal brain injury: evidence, mechanisms, and future translation. Cells. 2021;10:2766. https:\/\/doi.org\/10.3390\/cells10102766.","journal-title":"Cells."},{"key":"3022_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382. https:\/\/doi.org\/10.1038\/nmeth.2019.","journal-title":"Nat Methods"},{"key":"3022_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/glia.23546","volume":"67","author":"J Mairesse","year":"2019","unstructured":"Mairesse J, Zinni M, Pansiot J, Hassan-Abdi R, Demene C, Colella M, Charriaut-Marlangue C, Rideau Batista Novais A, Tanter M, Maccari S, et al. Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia. Glia. 2019;67:345\u201359. https:\/\/doi.org\/10.1002\/glia.23546.","journal-title":"Glia."},{"key":"3022_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17:41\u20134. https:\/\/doi.org\/10.1038\/s41592-019-0638-x.","journal-title":"Nat Methods"},{"key":"3022_CR27","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, Kundu DJ, Prakash A, Frericks-Zipper A, Eisenacher M, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543\u201352. https:\/\/doi.org\/10.1093\/nar\/gkab1038.","journal-title":"Nucleic Acids Res"},{"key":"3022_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbi.2013.02.005","volume":"32","author":"V Chhor","year":"2013","unstructured":"Chhor V, Le Charpentier T, Lebon S, Ore MV, Celador IL, Josserand J, Degos V, Jacotot E, Hagberg H, Savman K, et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun. 2013;32:70\u201385. https:\/\/doi.org\/10.1016\/j.bbi.2013.02.005.","journal-title":"Brain Behav Immun"},{"key":"3022_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.879649","volume":"16","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Wintermark P. The role of sildenafil in treating brain injuries in adults and neonates. Front Cell Neurosci. 2022;16: 879649. https:\/\/doi.org\/10.3389\/fncel.2022.879649.","journal-title":"Front Cell Neurosci"},{"key":"3022_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000448327","volume":"38","author":"A Yazdani","year":"2016","unstructured":"Yazdani A, Khoja Z, Johnstone A, Dale L, Rampakakis E, Wintermark P. Sildenafil improves brain injury recovery following term neonatal hypoxia-ischemia in male rat pups. Dev Neurosci. 2016;38:251\u201363. https:\/\/doi.org\/10.1159\/000448327.","journal-title":"Dev Neurosci"},{"key":"3022_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000457832","volume":"39","author":"J Engels","year":"2017","unstructured":"Engels J, Elting N, Braun L, Bendix I, Herz J, Felderhoff-Muser U, Dzietko M. Sildenafil enhances quantity of immature neurons and promotes functional recovery in the developing ischemic mouse brain. Dev Neurosci. 2017;39:287\u201397. https:\/\/doi.org\/10.1159\/000457832.","journal-title":"Dev Neurosci"},{"key":"3022_CR32","doi-asserted-by":"publisher","first-page":"22046","DOI":"10.1038\/s41598-021-01097-6","volume":"11","author":"A Yazdani","year":"2021","unstructured":"Yazdani A, Howidi B, Shi MZ, Tugarinov N, Khoja Z, Wintermark P. Sildenafil improves hippocampal brain injuries and restores neuronal development after neonatal hypoxia-ischemia in male rat pups. Sci Rep. 2021;11:22046. https:\/\/doi.org\/10.1038\/s41598-021-01097-6.","journal-title":"Sci Rep"},{"key":"3022_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/14767058.2010.492061","volume":"24","author":"O Ozdegirmenci","year":"2011","unstructured":"Ozdegirmenci O, Kucukozkan T, Akdag E, Topal T, Haberal A, Kayir H, Oter S, Akyol M, Uzbay T. Effects of sildenafil and tadalafil on ischemia\/reperfusion injury in fetal rat brain. J Matern Fetal Neonatal Med. 2011;24:317\u201323. https:\/\/doi.org\/10.3109\/14767058.2010.492061.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3022_CR34","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neuroscience.2009.11.046","volume":"165","author":"U Gomez-Pinedo","year":"2010","unstructured":"Gomez-Pinedo U, Rodrigo R, Cauli O, Herraiz S, Garcia-Verdugo JM, Pellicer B, Pellicer A, Felipo V. cGMP modulates stem cells differentiation to neurons in brain in vivo. Neuroscience. 2010;165:1275\u201383. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.11.046.","journal-title":"Neuroscience"},{"key":"3022_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/781512","volume":"2012","author":"K Shrivastava","year":"2012","unstructured":"Shrivastava K, Chertoff M, Llovera G, Recasens M, Acarin L. Short and long-term analysis and comparison of neurodegeneration and inflammatory cell response in the ipsilateral and contralateral hemisphere of the neonatal mouse brain after hypoxia\/ischemia. Neurol Res Int. 2012;2012: 781512. https:\/\/doi.org\/10.1155\/2012\/781512.","journal-title":"Neurol Res Int"},{"key":"3022_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010397","volume":"5","author":"K Jarlestedt","year":"2010","unstructured":"Jarlestedt K, Rousset CI, Faiz M, Wilhelmsson U, Stahlberg A, Sourkova H, Pekna M, Mallard C, Hagberg H, Pekny M. Attenuation of reactive gliosis does not affect infarct volume in neonatal hypoxic\u2013ischemic brain injury in mice. PLoS ONE. 2010;5: e10397. https:\/\/doi.org\/10.1371\/journal.pone.0010397.","journal-title":"PLoS ONE"},{"key":"3022_CR37","doi-asserted-by":"publisher","first-page":"9467","DOI":"10.1038\/s41598-023-36653-9","volume":"13","author":"H Sabir","year":"2023","unstructured":"Sabir H, Maes E, Zweyer M, Schleehuber Y, Imam FB, Silverman J, White Y, Pang R, Pasca AM, Robertson NJ, et al. Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial. Sci Rep. 2023;13:9467. https:\/\/doi.org\/10.1038\/s41598-023-36653-9.","journal-title":"Sci Rep"},{"key":"3022_CR38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000232556","volume":"31","author":"ZS Vexler","year":"2009","unstructured":"Vexler ZS, Yenari MA. Does inflammation after stroke affect the developing brain differently than adult brain? Dev Neurosci. 2009;31:378\u201393. https:\/\/doi.org\/10.1159\/000232556.","journal-title":"Dev Neurosci"},{"key":"3022_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12974-022-02654-0","volume":"19","author":"SR Shultz","year":"2022","unstructured":"Shultz SR, Shah AD, Huang C, Dill LK, Schittenhelm RB, Morganti-Kossmann MC, Semple BD. Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury. J Neuroinflammation. 2022;19:291. https:\/\/doi.org\/10.1186\/s12974-022-02654-0.","journal-title":"J Neuroinflammation"},{"key":"3022_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jnen\/nlx101","volume":"77","author":"K Kenney","year":"2018","unstructured":"Kenney K, Iacono D, Edlow BL, Katz DI, Diaz-Arrastia R, Dams-O\u2019Connor K, Daneshvar DH, Stevens A, Moreau AL, Tirrell LS, et al. Dementia after moderate-severe traumatic brain injury: coexistence of multiple proteinopathies. J Neuropathol Exp Neurol. 2018;77:50\u201363. https:\/\/doi.org\/10.1093\/jnen\/nlx101.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3022_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s13311-016-0467-x","volume":"14","author":"U Lindberg","year":"2017","unstructured":"Lindberg U, Witting N, Jorgensen SL, Vissing J, Rostrup E, Larsson HB, Kruuse C. Effects of sildenafil on cerebrovascular reactivity in patients with becker muscular dystrophy. Neurotherapeutics. 2017;14:182\u201390. https:\/\/doi.org\/10.1007\/s13311-016-0467-x.","journal-title":"Neurotherapeutics"},{"key":"3022_CR42","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2174\/138161208784705432","volume":"14","author":"B Engelhardt","year":"2008","unstructured":"Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des. 2008;14:1555\u201365. https:\/\/doi.org\/10.2174\/138161208784705432.","journal-title":"Curr Pharm Des"},{"key":"3022_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41390-021-01818-7","volume":"91","author":"J Herz","year":"2022","unstructured":"Herz J, Bendix I, Felderhoff-Muser U. Peripheral immune cells and perinatal brain injury: a double-edged sword? Pediatr Res. 2022;91:392\u2013403. https:\/\/doi.org\/10.1038\/s41390-021-01818-7.","journal-title":"Pediatr Res"},{"key":"3022_CR44","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/nu13113719","volume":"13","author":"M Zinni","year":"2021","unstructured":"Zinni M, Pansiot J, Colella M, Faivre V, Delahaye-Duriez A, Guillonneau F, Bruce J, Salnot V, Mairesse J, Knoop M, et al. Impact of fetal growth restriction on the neonatal microglial proteome in the rat. Nutrients. 2021;13:3719. https:\/\/doi.org\/10.3390\/nu13113719.","journal-title":"Nutrients."},{"key":"3022_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12974-021-02314-9","volume":"18","author":"M Seitz","year":"2021","unstructured":"Seitz M, Koster C, Dzietko M, Sabir H, Serdar M, Felderhoff-Muser U, Bendix I, Herz J. Hypothermia modulates myeloid cell polarization in neonatal hypoxic\u2013ischemic brain injury. J Neuroinflammation. 2021;18:266. https:\/\/doi.org\/10.1186\/s12974-021-02314-9.","journal-title":"J Neuroinflammation"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03022-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03022-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03022-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:07:46Z","timestamp":1706000866000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03022-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3022"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03022-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the local Ethics Committee in Animal Experimentation and by the institutional review board (Ministry of Higher Education and Scientific Research, Directorate-General for Research and Innovation, Paris, France (protocol number APAFiS #22114, January 28th 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}